PT Pyridam Farma Tbk(ID:PYFA)
Rp122.00+2.00 (+1.67%)
ID:PYFA
PT Pyridam Farma Tbk financials statements
Rp122.00
At close:+2.00 (+1.67%)
PT Pyridam Farma Tbk (PYFA) Ratios
PT Pyridam Farma Tbk Ratios
ID:PYFA's free cash flow for Q2 2026 was Rp-147.70B. For the 2026 fiscal year, ID:PYFA's free cash flow was decreased by Rp-22.63B and operating cash flow was Rp-125.07B. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Dec 23 | Mar 23 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.24 | 1.28 | 1.94 | 1.82 | 1.30 |
| Quick Ratio | 0.82 | 0.90 | 1.17 | 1.11 | 0.72 |
| Cash Ratio | 0.09 | 0.29 | 0.31 | 0.46 | 0.19 |
| Solvency Ratio | -0.02 | -0.03 | -0.02 | 0.32 | 0.06 |
| Operating Cash Flow Ratio | -0.32 | -0.12 | -0.35 | 0.93 | 0.16 |
| Short-Term Operating Cash Flow Coverage | -0.97 | -0.23 | -0.71 | 1.79 | 0.49 |
| Net Current Asset Value | Rp -4.36T | Rp -3.23T | Rp -593.63B | Rp -537.22B | Rp -312.69B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.72 | 0.67 | 0.65 | 0.60 | 0.56 |
| Debt-to-Equity Ratio | 6.31 | 3.72 | 2.77 | 2.06 | 2.69 |
| Debt-to-Capital Ratio | 0.86 | 0.79 | 0.73 | 0.67 | 0.73 |
| Long-Term Debt-to-Capital Ratio | 0.81 | 0.73 | 0.70 | 0.63 | 0.68 |
| Financial Leverage Ratio | 8.83 | 5.59 | 4.26 | 3.44 | 4.82 |
| Debt Service Coverage Ratio | 0.40 | 0.07 | 0.25 | 1.80 | 0.65 |
| Interest Coverage Ratio | -0.50 | -0.47 | 0.02 | 3.98 | 1.24 |
| Debt to Market Cap | 0.68 | 1.93 | 0.34 | 0.42 | 0.17 |
| Interest Debt Per Share | 459.86 | 482.19 | 430.74 | 400.03 | 196.91 |
| Net Debt to EBITDA | 36.86 | 44.89 | 14.78 | 1.84 | 4.79 |
| Profitability Margins | |||||
| Gross Profit Margin | 17.59% | 27.93% | 42.06% | 35.06% | 38.79% |
| EBIT Margin | -5.94% | -5.26% | 0.46% | 48.95% | 8.28% |
| EBITDA Margin | 4.66% | 4.08% | 8.65% | 58.90% | 13.28% |
| Operating Profit Margin | -5.94% | -5.56% | 0.27% | 48.34% | 8.23% |
| Pretax Profit Margin | -19.23% | -16.30% | -11.86% | 36.77% | 1.40% |
| Net Profit Margin | -13.75% | -17.19% | -12.14% | 38.47% | 0.87% |
| Continuous Operations Profit Margin | -13.75% | -17.19% | -12.14% | 38.50% | 0.87% |
| Net Income Per EBT | 71.52% | 105.46% | 102.37% | 104.62% | 62.18% |
| EBT Per EBIT | 323.50% | 292.99% | -4429.28% | 76.07% | 16.98% |
| Return on Assets (ROA) | -5.61% | -5.68% | -5.60% | 18.10% | 0.68% |
| Return on Equity (ROE) | -49.50% | -31.77% | -23.88% | 62.25% | 3.28% |
| Return on Capital Employed (ROCE) | -2.92% | -2.32% | 0.15% | 28.28% | 9.36% |
| Return on Invested Capital (ROIC) | -1.93% | -2.02% | 0.14% | 25.01% | 5.04% |
| Return on Tangible Assets | -9.58% | -10.25% | -5.67% | 18.24% | 0.72% |
| Earnings Yield | -7.10% | -18.53% | -2.95% | 12.77% | 0.22% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.63 | 2.94 | 3.43 | 4.64 | 6.24 |
| Payables Turnover | 7.77 | 5.78 | 6.47 | 6.76 | 4.05 |
| Inventory Turnover | 4.70 | 3.03 | 1.80 | 2.21 | 2.64 |
| Fixed Asset Turnover | 1.16 | 1.26 | 0.87 | 0.84 | 1.63 |
| Asset Turnover | 0.41 | 0.33 | 0.46 | 0.47 | 0.78 |
| Working Capital Turnover Ratio | 9.04 | 6.28 | 2.70 | 4.50 | 7.92 |
| Cash Conversion Cycle | 131.29 | 181.43 | 252.26 | 189.85 | 106.26 |
| Days of Sales Outstanding | 100.61 | 124.08 | 106.32 | 78.68 | 58.46 |
| Days of Inventory Outstanding | 77.65 | 120.54 | 202.34 | 165.14 | 138.02 |
| Days of Payables Outstanding | 46.97 | 63.19 | 56.39 | 53.97 | 90.22 |
| Operating Cycle | 178.27 | 244.62 | 308.66 | 243.82 | 196.48 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -32.42 | -16.62 | -41.72 | 110.44 | 15.88 |
| Free Cash Flow Per Share | -44.84 | -32.55 | -51.22 | 91.80 | -73.21 |
| Dividend Paid and CapEx Coverage Ratio | -2.61 | -0.85 | -4.39 | 5.92 | 0.18 |
| Capital Expenditure Coverage Ratio | -2.61 | -1.04 | -4.39 | 5.92 | 0.18 |
| Operating Cash Flow Coverage Ratio | -0.08 | -0.04 | -0.11 | 0.30 | 0.09 |
| Operating Cash Flow to Sales Ratio | -0.13 | -0.07 | -0.15 | 0.38 | 0.06 |
| Free Cash Flow Yield | -9.42% | -15.50% | -4.42% | 10.61% | -7.21% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -14.09 | -5.40 | -33.92 | 7.83 | 461.36 |
| Price-to-Sales (P/S) Ratio | 1.94 | 0.93 | 4.12 | 3.01 | 4.01 |
| Price-to-Book (P/B) Ratio | 6.97 | 1.71 | 8.10 | 4.88 | 15.14 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -10.61 | -6.45 | -22.65 | 9.42 | -13.86 |
| Price-to-Operating Cash Flow Ratio | -14.68 | -12.64 | -27.80 | 7.83 | 63.90 |
| Price-to-Earnings Growth (PEG) Ratio | 1.07 | -0.39 | 0.26 | 0.00 | -6.14 |
| Enterprise Value Multiple | 78.45 | 67.65 | 62.41 | 6.95 | 35.00 |
| Enterprise Value | 10.09T | 5.30T | 3.79T | 2.93T | 2.93T |
| EV to EBITDA | 78.45 | 67.65 | 62.41 | 6.95 | 35.00 |
| EV to Sales | 3.65 | 2.76 | 5.40 | 4.09 | 4.65 |
| EV to Free Cash Flow | -20.02 | -19.18 | -29.68 | 12.80 | -16.06 |
| EV to Operating Cash Flow | -27.69 | -37.56 | -36.43 | 10.64 | 74.03 |
| Tangible Book Value Per Share | -162.33 | -182.47 | 135.60 | 173.02 | 49.06 |
| Shareholders’ Equity Per Share | 68.26 | 122.47 | 143.18 | 177.41 | 67.05 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.28 | -0.05 | -0.02 | -0.05 | 0.38 |
| Revenue Per Share | 245.66 | 226.29 | 281.71 | 287.07 | 253.00 |
| Net Income Per Share | -33.79 | -38.91 | -34.20 | 110.44 | 2.20 |
| Tax Burden | 0.72 | 1.05 | 1.02 | 1.05 | 0.62 |
| Interest Burden | 3.23 | 3.10 | -25.60 | 0.75 | 0.17 |
| Research & Development to Revenue | 0.01 | 0.01 | 0.03 | 0.02 | 0.00 |
| SG&A to Revenue | 0.10 | 0.11 | 0.21 | 0.18 | 0.19 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.96 | 0.43 | 1.22 | 1.00 | 7.23 |
Currency in IDR
